Supplementary Figure. Trends in the Estimated Proportions and 95% CIs of SARS-CoV-2 Reverse Transcription–Polymerase Chain Reaction Results With S-Gene Target Presence and SARS-CoV-2 Variant Proportions or Nowcast Projections From Genomic Surveillance Classified As Exhibiting S-Gene Target Presence, Nationally and by Health and Human Services Regions 1–10 — United States, October 30, 2022–January 14, 2023

Details

• Alternative Title:
  COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022: Supplementary Figure. Trends in the Estimated Proportions and 95% CIs of SARS-CoV-2 Reverse Transcription–Polymerase Chain Reaction Results With S-Gene Target Presence and SARS-CoV-2 Variant Proportions or Nowcast Projections From Genomic Surveillance Classified As Exhibiting S-Gene Target Presence, Nationally and by Health and Human Services Regions 1–10 — United States, October 30, 2022–January 14, 2023
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2023; v. 72, no. 6
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pages in Document:
  1 pdf page
• Volume:
  72
• Issue:
  6
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:7979089233baa7375e6ba3b2aeffe7af4cf1fab839999bf8bbbdda196323a06146f6d1d1a105c1c382c0cc48e95249f8bca4c82c6d501ef7a3f45bc3001f5b82
• Download URL:
  https://stacks.cdc.gov/view/cdc/124201/cdc_124201_DS1.pdf
• File Type:
  [PDF - 301.73 KB ]